Latest News
All Times Eastern
- Will the ECB hike rates or not? Decision set to be cliff hanger as eurozone sentiment indicators deteriorate
- DocuSign shares rise after earnings, and other movers
- Barron's DocuSign, Apple, Smartsheet, Guidewire Software, RH, and More Stock Market Movers
- U.S. stock futures lean higher after difficult week on Wall Street
- Barron's Banks Are Stuck in a Rut. A Buyout Wave Could Be Building.
- Barron's High-Quality Dividend Stocks Are on Sale. Now Is the Time to Buy.
- Barron's Why Walt Disney Could Cave First in Its Cable Standoff With Charter
- Barron's 5 Federal Deficit Myths, Explained
- Barron's Walgreens Is Looking for a New CEO. Why That Could Make the Stock a Winner.
- Barron's Active Funds Rocked August. Passive Is Grabbing the Year.
to be replaced
Polarean Imaging PLC
POLXUK
p
-0.20
-1.74%
Open
p
11.30
| Previous Close |
|---|
| 11.50p |
Volume: 540.32K
65 Day Avg: 597.68K
11.13
Day Range
12.89
10.41
52 Week Range
84.20
Partner Center
Your Watchlists
Recently Viewed Tickers
Overview
POLX Overview
Key Data
- Open 12.50p
- Day Range 11.13 - 12.89
- 52 Week Range 10.41 - 84.20
- Market Cap £31.3M
- Shares Outstanding 215.85M
- Public Float 126.49M
- Beta 0.77
- Rev. per Employee N/A
- P/E Ratio N/A
- EPS -£0.06
- Yield N/A
- Dividend N/A
- Ex-Dividend Date N/A
- Short Interest N/A
- % of Float Shorted N/A
- Average Volume 597.68K
Performance
| 5 Day |
|
| 1 Month |
|
| 3 Month |
|
| YTD |
|
| 1 Year |
|
Analyst Ratings
Number of Ratings 1
Full Ratings
Polarean Imaging PLC
Polarean Imaging Plc. operates as a medical drug-device combination company serving the medical imaging market in the United States and internationally. The firm manufactures, sells, and services hyperpolarizes and ancillary equipment for biomedical imaging research. It develops equipment that enables existing magnetic resonance imaging (MRI) systems to achieve a level of pulmonary functional imaging and specializes in the use of hyperpolarized Xenon gas (129Xe) as an imaging agent to visualize ventilation and gas exchange regionally in the smallest airways of the lungs, the tissue barrier between the lung and the bloodstream, and in the pulmonary vasculature; and a novel diagnostic approach. It also develops and manufactures MRI radiofrequency coils, which are required components for imaging 129Xe in the MRI system. The company was founded on October 24, 2016 and is headquartered in London, the United Kingdom.